vs
Side-by-side financial comparison of Enovis CORP (ENOV) and MetLife (MET). Click either name above to swap in a different company.
MetLife is the larger business by last-quarter revenue ($19.1B vs $589.2M, roughly 32.4× Enovis CORP). MetLife runs the higher net margin — 6.0% vs -1.4%, a 7.4% gap on every dollar of revenue. On growth, Enovis CORP posted the faster year-over-year revenue change (5.4% vs 2.7%). Over the past eight quarters, MetLife's revenue compounded faster (484.7% CAGR vs 5.9%).
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.
MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.
ENOV vs MET — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $589.2M | $19.1B |
| Net Profit | $-8.4M | $1.1B |
| Gross Margin | 62.0% | — |
| Operating Margin | — | — |
| Net Margin | -1.4% | 6.0% |
| Revenue YoY | 5.4% | 2.7% |
| Net Profit YoY | — | 30.0% |
| EPS (diluted) | $-0.15 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $589.2M | $19.1B | ||
| Q4 25 | $548.9M | $600.0M | ||
| Q3 25 | $564.5M | $621.0M | ||
| Q2 25 | $558.8M | $604.0M | ||
| Q1 25 | — | $611.0M | ||
| Q4 24 | $561.0M | $556.0M | ||
| Q3 24 | $505.2M | $554.0M | ||
| Q2 24 | $525.2M | $558.0M |
| Q1 26 | $-8.4M | $1.1B | ||
| Q4 25 | $-571.1M | $809.0M | ||
| Q3 25 | $-36.7M | $896.0M | ||
| Q2 25 | $-56.0M | $729.0M | ||
| Q1 25 | — | $945.0M | ||
| Q4 24 | $-703.2M | $1.3B | ||
| Q3 24 | $-31.5M | $1.3B | ||
| Q2 24 | $-18.6M | $946.0M |
| Q1 26 | 62.0% | — | ||
| Q4 25 | 59.9% | — | ||
| Q3 25 | 59.3% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 54.8% | — | ||
| Q3 24 | 56.7% | — | ||
| Q2 24 | 55.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | -101.7% | — | ||
| Q3 25 | -3.0% | — | ||
| Q2 25 | -8.4% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -118.5% | — | ||
| Q3 24 | -6.3% | — | ||
| Q2 24 | -8.4% | — |
| Q1 26 | -1.4% | 6.0% | ||
| Q4 25 | -104.1% | 134.8% | ||
| Q3 25 | -6.5% | 144.3% | ||
| Q2 25 | -10.0% | 120.7% | ||
| Q1 25 | — | 154.7% | ||
| Q4 24 | -125.4% | 228.6% | ||
| Q3 24 | -6.2% | 242.2% | ||
| Q2 24 | -3.5% | 169.5% |
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-9.99 | $1.18 | ||
| Q3 25 | $-0.64 | $1.22 | ||
| Q2 25 | $-0.98 | $1.03 | ||
| Q1 25 | — | $1.28 | ||
| Q4 24 | $-12.69 | $1.75 | ||
| Q3 24 | $-0.58 | $1.81 | ||
| Q2 24 | $-0.34 | $1.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $33.1M | — |
| Total DebtLower is stronger | $1.3B | $14.8B |
| Stockholders' EquityBook value | $1.5B | $27.6B |
| Total Assets | $3.8B | $743.2B |
| Debt / EquityLower = less leverage | 0.90× | 0.54× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $33.1M | — | ||
| Q4 25 | $33.6M | $25.6B | ||
| Q3 25 | $44.1M | $26.2B | ||
| Q2 25 | $38.5M | $27.5B | ||
| Q1 25 | — | $26.9B | ||
| Q4 24 | $48.2M | $25.2B | ||
| Q3 24 | $35.4M | $26.4B | ||
| Q2 24 | $35.0M | $24.6B |
| Q1 26 | $1.3B | $14.8B | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
| Q1 26 | $1.5B | $27.6B | ||
| Q4 25 | $2.0B | $28.4B | ||
| Q3 25 | $2.6B | $28.9B | ||
| Q2 25 | $2.6B | $27.7B | ||
| Q1 25 | — | $27.5B | ||
| Q4 24 | $2.6B | $27.4B | ||
| Q3 24 | $3.3B | $30.9B | ||
| Q2 24 | $3.3B | $27.3B |
| Q1 26 | $3.8B | $743.2B | ||
| Q4 25 | $4.4B | $745.2B | ||
| Q3 25 | $5.0B | $719.7B | ||
| Q2 25 | $4.9B | $702.5B | ||
| Q1 25 | — | $688.3B | ||
| Q4 24 | $4.7B | $677.5B | ||
| Q3 24 | $5.6B | $705.0B | ||
| Q2 24 | $5.4B | $675.7B |
| Q1 26 | 0.90× | 0.54× | ||
| Q4 25 | 0.67× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.53× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 0.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENOV
Segment breakdown not available.
MET
| Premiums, fees and other revenues | $14.3B | 75% |
| Other | $4.8B | 25% |
